Filing Details

Accession Number:
0001209191-23-020299
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-21 16:47:36
Reporting Period:
2022-10-24
Accepted Time:
2023-03-21 16:47:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645569 Dice Therapeutics Inc. DICE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356950 Paul James Scopa C/O Dice Therapeutics, Inc.
400 East Jamie Court, Suite 300
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-24 30,719 $0.00 22,122 No 4 G Direct
Common Stock Acquisiton 2022-10-24 30,719 $0.00 33,719 No 4 G Indirect By Trust
Common Stock Disposition 2023-03-17 10,000 $29.05 23,719 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 G Indirect By Trust
No 4 S Indirect By Trust
Footnotes
  1. Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration.
  2. These securities are held of record by The James P. Scopa and Anne E. Kenner Family Trust, Anne E. Kenner and James P. Scopa, Trustees.